CMMI & Innovation
Expert articles and analysis related to cmmi & innovation.
AI Summary — Last 7 Days
In the past week, CMS has intensified its focus on advancing value-based care, as demonstrated by its bold shift towards utilizing regulatory measures to create a new paradigm in care delivery. This includes the proposed changes outlined in the MGMA report on CMS's 2030 value-based care push, which lays out both opportunities and challenges for stakeholders as they prepare for significant changes in care models. Concurrently, the implementation of the ACCESS Model, supported by the Framework for Health Innovation Technologies, aims to promote interoperability and enhance collaboration across healthcare ecosystems.
Related Articles
HHS to Invest $840M to Promote Healthcare Reform
HHS to Invest $840M to Promote Healthcare Reform  AAPC
How can providers succeed in CMS TEAM?
How can providers succeed in CMS TEAM?  Guidehouse
CMS All-In On Using ‘Big Stick’ To Make Value-Based Care New Paradigm
CMS All-In On Using ‘Big Stick’ To Make Value-Based Care New Paradigm  Forbes
MGMA outlines path and pitfalls in CMS 2030 value-based care push
MGMA outlines path and pitfalls in CMS 2030 value-based care push  HealthExec
CMS Policy Deep Dives
From newsletter: Mapping the ACCESS Model APIs: What the FHIR Infrastructure Tells Us About Who Should Participate, and Who They’ll… Mapping the ACCESS Model APIs: What the FHIR Infrastructure Tells U...
CMS opens grant applications for MAHA ELEVATE lifestyle medicine model
CMS opens grant applications for MAHA ELEVATE lifestyle medicine model  Fierce Healthcare
Keeping humans in the AI/ML loop at CMS
Potential Swings in County-Level Benchmarks: Understanding the Nuanced Impacts of CMS’s Proposed Changes for 2027
CMS’s Calendar Year 2027 Advance Notice, released on January 26, 2026, proposed changes to fee-for-service (FFS) expenditures and introduced a new risk adjustment model. Together, these updates could ...
STAT+: White House digs in on ‘most-favored nation’ drug pricing despite Congress’ cool reception
Despite a cool reception from Congress, the White House is looking to intensify its pressure campaign on lawmakers to pass a “most-favored nation" drug pricing bill.